Guidance for developers of health research reporting guidelines - PubMed (original) (raw)

Guidance for developers of health research reporting guidelines

David Moher et al. PLoS Med. 2010.

Abstract

David Moher and colleagues from the EQUATOR network offer guidance and recommended steps for developing health research reporting guidelines.

PubMed Disclaimer

Conflict of interest statement

Competing interests: DM, KFS, IS, and DGA are members of the EQUATOR Network. DM, KFS, and DGA are members of the CONSORT executive. DM and DGA are members of the PRISMA executive. DM is on the Editorial Board of PLoS Medicine.

Similar articles

Cited by

References

    1. Glasziou P, Meats E, Heneghan C, Shepperd S. What is missing from descriptions of treatment in trials and reviews? BMJ. 2008;336 (7659):1472–4. - PMC - PubMed
    1. Zhang D, Yin P, Freemantle N, Jordan R, Zhong N, et al. An assessment of the quality of randomised controlled trials conducted in China. Trials. 2008;9:22. - PMC - PubMed
    1. Scales CD, Norris RD, Preminger GM, Vieweg J, Peterson BL, et al. Evaluating the evidence: statistical methods in randomized controlled trials in the urological literature. J Urol. 2008;180:1463–1467. - PubMed
    1. Lai TYY, Wong VWY, Lam RF, Cheng ACO, Lam DSC, et al. Quality of reporting of key methodological items of randomized controlled trials in clinical ophthalmic journals. Ophthalmic Epidemiol. 2008;14:390–398. - PubMed
    1. Chan AW, Altman DG. Epidemiology and reporting of randomised trials published in PubMed journals. Lancet. 2005;365 (9465):1159–62. - PubMed

Publication types

MeSH terms

LinkOut - more resources